Press Releases
-
3 Jun, 2026The subscription period in Spago Nanomedical’s rights issue begins today
-
2 Jun, 2026Spago Nanomedical publishes information document in connection with forthcoming rights issue
-
22 May, 2026Spago Nanomedical resolves on a rights issue of approximately SEK 16 million
-
19 May, 2026Spago Nanomedical publishes the annual report for 2025
-
18 May, 2026Spago Nanomedical presents Tumorad® clinical data at the international ANZSNM 2026 conference